Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Search

Search

Popular Search Terms:
Companies / How to Trade / CEO & Team / Contact / List of Brokers

PPM:JPJ

500.0 GBX

AGRW1:JPJ

2.00 GBX

AGRW2:JPJ

2.0 GBX

AMT:JPJ

80.0 GBX

BIB:JPJ

TBC GBX

BVX:JPJ

10.5 GBX

BLVN:JPJ

0.28 GBX

CDR:JPJ

45.0 GBX

CMB:JPJ

0.45 GBX

CSS:JPJ

12.0 GBX

DEST:JPJ

3.00 GBX

ETX:JPJ

15.0 GBX

ERS:JPJ

5.0 GBX

FCRM:JPJ

0.17 GBX

GEEC:JPJ

4.2 GBX

GSV:JPJ

53.0 GBX

GYG:JPJ

30.15 GBX

HVS:JPJ

5.00 GBX

IBPO:JPJ

59.8 GBX

ITHL:JPJ

475.0 GBX

IPG:JPJ

66.7 GBX

LDSG:JPJ

6.25 GBX

LEXW:JPJ

1.0 GBX

LOOP:JPJ

0.7 GBX

LPM:JPJ

45.0 GBX

MEN:JPJ

7.5 GBX

OMM:JPJ

150.0 GBX

MEAL:JPJ

1.5 GBX

PRAX1:JPJ

1.77 GBX

PRAX2:JPJ

2.0 GBX

QFH:JPJ

2200.0 GBX

QUIZ:JPJ

0.64 GBX

REC:JPJ

0.035 EUR

REDX:JPJ

15.0 GBX

RGH:JPJ

70.0 GBX

SCHO:JPJ

44.0 GBX

SND:JPJ

1.35 GBX

SPO:JPJ

85.0 GBX

SDRY:JPJ

3.29 GBX

TAL:JPJ

3.0 GBX

TNDE:JPJ

2.0 GBX

INGT:JPJ

43.0 GBX

THRV:JPJ

188.0 GBX

PPM:JPJ

500.0 GBX

AGRW1:JPJ

2.00 GBX

AGRW2:JPJ

2.0 GBX

AMT:JPJ

80.0 GBX

BIB:JPJ

TBC GBX

BVX:JPJ

10.5 GBX

BLVN:JPJ

0.28 GBX

CDR:JPJ

45.0 GBX

CMB:JPJ

0.45 GBX

CSS:JPJ

12.0 GBX

DEST:JPJ

3.00 GBX

ETX:JPJ

15.0 GBX

ERS:JPJ

5.0 GBX

FCRM:JPJ

0.17 GBX

GEEC:JPJ

4.2 GBX

GSV:JPJ

53.0 GBX

GYG:JPJ

30.15 GBX

HVS:JPJ

5.00 GBX

IBPO:JPJ

59.8 GBX

ITHL:JPJ

475.0 GBX

IPG:JPJ

66.7 GBX

LDSG:JPJ

6.25 GBX

LEXW:JPJ

1.0 GBX

LOOP:JPJ

0.7 GBX

LPM:JPJ

45.0 GBX

MEN:JPJ

7.5 GBX

OMM:JPJ

150.0 GBX

MEAL:JPJ

1.5 GBX

PRAX1:JPJ

1.77 GBX

PRAX2:JPJ

2.0 GBX

QFH:JPJ

2200.0 GBX

QUIZ:JPJ

0.64 GBX

REC:JPJ

0.035 EUR

REDX:JPJ

15.0 GBX

RGH:JPJ

70.0 GBX

SCHO:JPJ

44.0 GBX

SND:JPJ

1.35 GBX

SPO:JPJ

85.0 GBX

SDRY:JPJ

3.29 GBX

TAL:JPJ

3.0 GBX

TNDE:JPJ

2.0 GBX

INGT:JPJ

43.0 GBX

THRV:JPJ

188.0 GBX

Category: Destiny

Decision of the Board to Appoint Administrators

Destiny Pharma plc(“Destiny Pharma” or “the Company”) Decision of the Board of Directors to Appoint Administrators. Brighton, United Kingdom – 22 August 2024 – Destiny Pharma, a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life threatening infections, today announces that further to the announcement of 15 July when it communicated its intention to delist and the subsequent […]

Destiny Pharma plc shares now trading on JP Jenkins

JP Jenkins LtdDestiny Pharma plc shares now trading on JP Jenkins 13-Aug-2024 / 07:00 GMT/BSTThe issuer is solely responsible for the content of this announcement. 13th Aug 2024 JPJ: DEST ISIN: GB00B60BD277 Destiny Pharma plc (“Destiny Pharma” or “the Company”) Shares now trading on JP Jenkins London, UK, 13th Aug 2024 – Destiny Pharma plc […]

Last Day of Dealings on AIM

Destiny Pharma plc(“Destiny Pharma” or “the Company”) Last Day of Dealings on AIM Brighton, United Kingdom ‐ 12 August 2024 ‐ Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life‐threatening infections, reminds shareholders that the last day of trading in Destiny […]

0207 469 0937

info@jpjenkins.com

5th Floor
101 Wigmore St
London
W1U 1QU

Linkedin Facebook X-twitter

Copyright © 2023 JP Jenkins. All rights reserved. JP Jenkins is a trading name of Infinitx Limited a company incorporated in England & Wales with registered number 11551708 and whose registered office is at 101 Wigmore Street, 5th Floor, London, England, W1U 1QU (JPJ). JPJ (FRN 950991) is an appointed representative of Prosper Capital LLP (FRN453007) (Prosper) which is authorised and regulated by the Financial Conduct Authority. This website is a financial promotion by JPJ. It is not intended to be a promotion of any individual investment opportunity and is not an offer to the public. JPJ acts for the companies listed on the website and provides services to authorised brokers but does not act for investors, consumers or any other person. The information on this website is obtained from the companies and other third parties and although JPJ considers these sources to be reliable, it makes no representation as to the accuracy of the information. Neither JPJ, Prosper nor any member of their group provides any advice on investing in unlisted shares generally or in the companies listed on the platform specifically, nor any legal, financial or tax advice of any kind. Nothing on this website and no communication from JPJ should be construed as an investment recommendation. If you have any doubt about the suitability of the investment, or you require financial advice, you should seek a personal recommendation from an appropriately qualified financial advisor. Investing in unlisted shares is high risk and should only be done as part of a diversified portfolio. Please read the RISK WARNINGS before making any investment decisions. Offers are only available through authorised persons. Any person resident outside the United Kingdom should ensure that they are not subject to any local regulations before investing. Nothing on this website constitutes an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. If you have any questions regarding these matters relating to information on this website you should consult a professional adviser.